AI Verdict
KAPA has stronger fundamentals based on our AI analysis.
KAPA vs KALU Fundamental Comparison
| Metric | KAPA | KALU |
|---|---|---|
| Revenue | N/A | $3.4B |
| Net Income | $-5.4M | $112.5M |
| Net Margin | N/A | 3.3% |
| ROE | -85.9% | 13.6% |
| ROA | -83.3% | 4.4% |
| Current Ratio | 27.07x | 2.95x |
| Debt/Equity | 0.00x | 1.28x |
| EPS | $-0.30 | $6.77 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
KAPA vs KALU: Frequently Asked Questions
Is KAPA or KALU a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), KAPA has stronger fundamentals. KAPA is rated SELL (85% confidence) while KALU is rated SELL (68% confidence). This is not investment advice.
How does KAPA compare to KALU fundamentally?
Kairos Pharma, LTD. has ROE of -85.9% vs KAISER ALUMINUM CORP's 13.6%. Net margins are N/A vs 3.3% respectively.
Which stock pays higher dividends, KAPA or KALU?
KAPA has a dividend yield of N/A or no dividend while KALU has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in KAPA or KALU for long term?
For long-term investing, consider that KAPA has SELL rating with 85% confidence, while KALU has SELL rating with 68% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about KAPA vs KALU?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For KAPA vs KALU, the AI consensus favors KAPA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.